Search

everythinglearnresearchcommunity

for

Search:↓

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

New treatments for male hypogonadism are effective and should be personalized.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

SHBG may be a useful early indicator and treatment target for PCOS.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Early balding linked to higher heart disease risk.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.